|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 15/113 | (2010.01) |
| A61K 31/713 | (2006.01) |
| (11) | Number of the document | 3105331 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15705888.4 |
| Date of filing the European patent application | 2015-02-11 | |
| (97) | Date of publication of the European application | 2016-12-21 |
| (45) | Date of publication and mention of the grant of the patent | 2021-06-23 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/015367 |
| Date | 2015-02-11 |
| (87) | Number | WO 2015/123264 |
| Date | 2015-08-20 |
| (30) | Number | Date | Country code |
| 201461938567 P | 2014-02-11 | US |
| (72) |
FITZGERALD, Kevin , US
BETTENCOURT, Brian , US
HINKLE, Gregory , US
WILLOUGHBY, Jennifer , US
|
| (73) |
Alnylam Pharmaceuticals, Inc. ,
300 Third Street, 3rd Floor, Cambridge, MA 02142,
US
|
| (54) | KETOHEXOKINASE (KHK) IRNA COMPOSITIONS AND METHODS OF USE THEREOF |
| KETOHEXOKINASE (KHK) IRNA COMPOSITIONS AND METHODS OF USE THEREOF |